tirzepatide similares medications similar to united states Ivím Health FDA Approves New Weight Loss

Additionally, competitors' doses don't always meet the level that scientific research would suggest they should

From diabetes to longevity Originally developed for type 2 diabetes, GLP-1s are now approved for weight loss and increasingly for other conditions including cardiovascular disease, kidney disease, and sleep apnoea with trials underway for Alzheimers, addiction, and even osteoarthritis

State pharmacy boards oversee most compounding pharmacies around the U.S., but if a pharmacy isn't registered or licensed in a state where it's shipping products, it can be hard to track

Members will still need a prescription to purchase either medication